Literature DB >> 6609932

Lymphocyte-reactive antibodies in acquired immune deficiency syndrome.

R C Williams, H Masur, T J Spira.   

Abstract

Antilymphocyte antibodies were studied using the Terasaki microcytotoxicity technique in 21 gay patients including 7 with Kaposi's sarcoma, 5 with opportunistic infection, and 9 with lymphadenopathy syndrome. A significant increase in lymphocyte-reactive antibody was noted in 61% of this group. Similar studies using serum from 25 apparently healthy gay males showed lymphocytotoxic antibody in only one instance. When isolated T-cell subsets (OKT4+ or OKT8+) were utilized, a few sera from acquired immune deficiency syndrome (AIDS) patients apparently showed preferential killing for helper-inducer or suppressor-cytotoxic T-cell subsets, however, this showed no correlation with T-cell phenotypic profiles of OKT4 or OKT8+ cells in concurrent peripheral blood studies. When isolated normal OKT4 or OKT8 T-cell subsets were treated with complement and AIDS serum showing apparent T-cell subset specificity and treated T cells added to B cells, macrophages, and OKT4 or OKT8 cells cultured with pokeweed mitogen, no discernible effect on either help or suppression of IgG or IgM synthesis was recorded.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609932     DOI: 10.1007/bf00915045

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  28 in total

1.  Lymphocytotoxic antibodies in disease.

Authors:  R L Dawkins; C Witt; J Richmond; K Sagenschneider; P J Zilko
Journal:  Aust N Z J Med       Date:  1978

2.  Antibodies in the sera of patients with systemic lupus erythematosus that block the binding of monoclonal anti-Ia to Ia-positive targets also inhibit the autologous mixed lymphocyte response.

Authors:  K Okudaira; R P Searles; J S Goodwin; R C Williams
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

3.  Update on Kaposi's sarcoma and opportunistic infections in previously healthy persons--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1982-06-11       Impact factor: 17.586

4.  Identification of DNA-binding lymphocytes in patients with systemic lupus erythematosus.

Authors:  A D Bankhurst; R C Williams
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

5.  Acquired immunodeficiency syndrome in a patient with hemophilia.

Authors:  K C Davis; C R Horsburgh; U Hasiba; A L Schocket; C H Kirkpatrick
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

6.  Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state.

Authors:  A E Pitchenik; M A Fischl; G M Dickinson; D M Becker; A M Fournier; M T O'Connell; R M Colton; T J Spira
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

7.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

8.  Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions.

Authors:  F P Siegal; C Lopez; G S Hammer; A E Brown; S J Kornfeld; J Gold; J Hassett; S Z Hirschman; C Cunningham-Rundles; B R Adelsberg
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

9.  Acquired immune deficiency in Haitians: opportunistic infections in previously healthy Haitian immigrants.

Authors:  J Vieira; E Frank; T J Spira; S H Landesman
Journal:  N Engl J Med       Date:  1983-01-20       Impact factor: 91.245

10.  Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions.

Authors:  P Wernet; H G Kunkel
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  15 in total

1.  Acquired immune deficiency syndrome (AIDS) and autoimmunity--mutually exclusive entities?

Authors:  A M Solinger; L E Adams; A E Friedman-Kien; E V Hess
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

2.  Natural IgM Switches the Function of Lipopolysaccharide-Activated Murine Bone Marrow-Derived Dendritic Cells to a Regulatory Dendritic Cell That Suppresses Innate Inflammation.

Authors:  Peter I Lobo; Kailo H Schlegel; Amandeep Bajwa; Liping Huang; Elvira Kurmaeva; Binru Wang; Hong Ye; Thomas F Tedder; Gilbert R Kinsey; Mark D Okusa
Journal:  J Immunol       Date:  2015-10-30       Impact factor: 5.422

3.  Lymphocyte autoantibodies and alloantibodies in HIV-positive haemophilia patients.

Authors:  V Daniel; K Schimpf; G Opelz
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

4.  The acquired immunodeficiency syndrome (AIDS).

Authors:  F S Rosen
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

5.  Humoral-mediated suppression of interleukin 2-dependent target cell proliferation in acquired immune deficiency syndrome (AIDS): interference with normal IL-2 receptor expression.

Authors:  R P Donnelly; M F La Via; K Y Tsang
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

6.  The significance of antilymphocyte antibodies in patients with acquired immune deficiency syndrome (AIDS) and their sexual partners.

Authors:  G E Ozturk; P F Kohler; C R Horsburgh; C H Kirkpatrick
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

7.  The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.

Authors:  W J Boyko; M T Schechter; E Jeffries; B Douglas; M Maynard; M O'Shaughnessy
Journal:  Can Med Assoc J       Date:  1985-07-01       Impact factor: 8.262

8.  Inhibition of interleukin-2-induced T-cell proliferation by sera from patients with the acquired immune deficiency syndrome.

Authors:  R P Donnelly; K Y Tsang; G M Galbraith; J I Wallace
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

9.  Differential isotype expression and binding properties of T cell-reactive antibodies in human immunodeficiency virus (HIV) infection.

Authors:  F Silvestris; C Azzolini; F Dammacco
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

10.  Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.

Authors:  A M Prince; B Horowitz; L Baker; R W Shulman; H Ralph; J Valinsky; A Cundell; B Brotman; W Boehle; F Rey
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.